Znn3bq.jpeg
²é¿´: 1272  |  »Ø¸´: 2

ÓÐÈË¿´µ½ÎҵĶú»

Ìú³æ (³õÈëÎÄ̳)

[½»Á÷] Ìì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÕÔÀö½ÌÊÚ¿ÎÌâ×齲ʦ¡¢²©ºó¼°¿ÆÑÐÖúÀíÕÐÆ¸

¾ßÌ幤×÷µØµã:
Ìì½òÊÐºÍÆ½ÇøÆøÏǫ́·22ºÅÌì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§Ôº
н½ð:
ÔÂн°ËǧÖÁÒ»Íò
ѧÀúºÍÑо¿·½Ïò:
ÉúÎҽѧ¡¢Ò©Ñ§µÈ
ÕÐÆ¸¸Úλ:
½²Ê¦/²©ºó/¿ÆÑÐÖúÀí
¹«Ë¾Ãû³Æ:
Ìì½òÒ½¿Æ´óѧ
ÁªÏµ·½Ê½:
shzhaoli@tmu.edu.cn

¿ÎÌâ×é½éÉÜ
       ÕÔÀö½ÌÊÚΪÌì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÉúÎﻯѧÓë·Ö×ÓÉúÎïѧϵ½ÌÊÚ£¬Ìì½òÊÐÌØÆ¸½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£
       ¿ÎÌâ×鳤ÆÚÖÂÁ¦ÓÚÁ˽âÏÂÇðÄÔ-´¹Ì壬¼××´ÏÙ£¬ÈéÏÙµÈÉñ¾­ÄÚ·ÖÃÚ»·Â·ÖÐµÄÆ÷¹Ù·¢Óý£¬²¢ÒÔ´ËÍÆ½ø¶ÔÏà¹Ø¼²²¡ºÍ°©Ö¢·¢Éú»úÖÆµÄÀí½â¡£ÀûÓÃת»ùÒòСÊó¹¹½¨¸÷ÖÖÌù½üÁÙ´²ÉúÀí¼²²¡ºÍ°©Ö¢µÄ¶¯Îï¼²²¡Ä£ÐÍ£»½Òʾ²¢×·×ÙÆ÷¹Ù·¢ÓýºÍÖ×Áö·¢ÉúµÄ¹Ø¼üÆðʼϸ°ûµÄ£»ÒÔǰÆÚ·Ö×Ó»úÖÆÍÚ¾òºÍÄÉÃ×°ÐÏòÒ©ÎïµÄ¿ª·¢ÓëµÝËÍΪ»ù´¡£¬Îª°©Ö¢ÖÎÁÆÌرðÊÇÄÑÖÎÐÔ¡¢×ªÒÆÐÔ°©Ö¢µÄÖÎÁÆÌṩ°ÐÏòÐÔÓëÓÐЧÐԸߡ¢¸±×÷ÓÃСµÄÖÎÁƲßÂÔ¡£
¿ÎÌâ×é³É¹û£º
       ·¢±íÔÚMolecular Cell¡¢Developmental Cell¡¢Nature Communications¡¢Development¡¢Oncogene¡¢Journal of Bone and Mineral Research¡¢ACS NanoµÈÔÓÖ¾20ÓàÆª¡£
1. Zhang Z, Wu Y, Fu J, Yu X, Su Y, Jia S, Cheng H, Shen Y, He X, Ren K, Zheng X, Guan H, Rao F, Zhao L. (2024) Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.Nat Commun. 15(1):4108.
2. Zhang P, Guan L, Sun W, Zhang Y, Du Y, Yuan S, Cao X, Yu Z, Jia Q, Zheng X, Meng Z, Li X, Zhao L.(2024) Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAFV600E-associated thyroid carcinoma. Clin Transl Med. 14(5):e1694.
3. Su Y, Luo Y, Zhang P, Lin H, Pu W, Zhang H, Wang H, Hao Y, Xiao Y, Zhang X, Wei X, Nie S,Zhang K, Fu Q, Chen H, Huang N, Ren Y, Wu M, Chow BKC, Chen X, Jin W, Wang F, Zhao L*, Rao F*. (2023) Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis. Mol Cell. 83(13):2316-2331.e7.
4¡¢Zhang P, Guan H, Yuan S, Cheng H, Zhang Z, Zheng J, Yu Y, Meng Z, Zheng X, Zhao L*. (2022) Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors. Nat Commun. 13(1):1588
5¡¢Yuan S, Zhang P, Wen L, Jia S, Wu Y, Zhang Z, Guan L, Yu Z, Zhao L*. (2021) miR-22 promotes stem cell traits via activating Wnt/¦Â-catenin signaling in cutaneous squamous cell carcinoma. Oncogene. 40(39):5799-5813
6¡¢Bi X, Lou P, Song Y, Sheng X, Liu R, Deng M, Yang X, Li G, Zhang B, Xue L, Liu Z, Plikus M, Ren F, Gao S, Yuan S, Zhang H, Jiao B, Zhao L*, Yu Z* (2021) Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway. Oncogene. 40(29):4832-4845
ÕÐÆ¸¸Úλ¼°ÒªÇó£º
1. ¿ÆÑÐÖúÀí1Ãû£ºÄêÁä¡Ü30ÖÜË꣬¾ßÓÐ˶ʿÑо¿Éú¼°ÒÔÉÏѧÀúºÍѧ룬ÉúÎҽѧ¡¢Ò©Ñ§µÈÏà¹Ø×¨Òµ·½Ïò¡£ÈȰ®¿ÆÑУ¬³Ô¿àÄÍÀÍ£¬¾ßÓÐÍŶÓЭ×÷¾«Éñ£¡ÊìÁ·ÕÆÎÕϸ°ûÅàÑø¡¢»ù±¾µÄÉú»¯ºÍ·Ö×ÓÉúÎïѧʵÑé¼¼ÄÜ£¬µÚ1×÷Õß·¢±íÓÐSCIÂÛÎÄÕßÓÅÏÈ¡£
2. ½²Ê¦1Ãû£¬²©Ê¿ºó1Ãû£ºÄêÁä¡Ü35ÖÜË꣬¾ßÓв©Ê¿Ñо¿ÉúѧÀúºÍѧ룬Ö×Áö¡¢ÌÇÖ¬´úлºÍ±í¹ÛÒÅ´«µÈÏà¹Ø×¨Òµ·½Ïò¡£ÈȰ®¿ÆÑУ¬³Ô¿àÄÍÀÍ£¬¾ßÓÐÍŶÓЭ×÷¾«Éñ£¡È¡µÃ½ÏºÃµÄÑо¿³É¹û£¨ÒÔµÚ1×÷Õß·¢±íQ1ÇøSCIÂÛÎÄÕßÓÅÏÈ£©²¢ÇҾ߱¸Á¼ºÃµÄ·¢Õ¹Ç±Á¦£»¾ßÓжÀÁ¢µÄ¿ÎÌâÉè¼ÆÄÜÁ¦ºÍÔúʵµÄʵÑé²Ù×÷ÄÜÁ¦£¬Äܹ»ÔÚPIµÄÖ¸µ¼Ï¶ÀÁ¢Õ¹¿ªÑо¿¹¤×÷£¬²¢²ÎÓëÑо¿ÉúµÄÖ¸µ¼¹¤×÷¡£

н³ê´ýÓö£º
1. ´ýÓö²ÎÕÕÌì½òÒ½¿Æ´óѧÏà¹ØÈËÊÂÕþ²ß²¢´ÓÓÅ¡£
2. Ìṩ¿ÆÑÐÖ¸µ¼£¬²Î¼Ó¹úÄÚÍâѧÊõ»áÒéµÄ»ú»á£¬È«Á¦Ö§³ÖÉêÇë¸÷ÖÖ»ù½ðºÍÈ˲ÅÏîÄ¿¡£
3. ¿ÆÑÐÖúÀíÒµÎñÊìÁ·Õß¿ÉÍÆ¼ö¼ÌÐø¶Á²©

»¶Ó­Ö¾È¤ÏàͶ¡¢ÈȰ®¿ÆÑС¢Çڷܿ̿àµÄ¿ÆÑÐÖúÀí¡¢²©Ê¿ºóºÍ½²Ê¦Ó¦Æ¸Õß¼ÓÈë¿ÎÌâ×飡

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

½ðÔÀÔÀÔÀÒ©

гæ (³õÈëÎÄ̳)

½ñÄê6Ô²űÏÒµ¿ÉÒÔÂð
2Â¥2025-02-26 10:37:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÓÐÈË¿´µ½ÎҵĶú»

Ìú³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by ½ðÔÀÔÀÔÀÒ© at 2025-02-26 10:37:19
½ñÄê6Ô²űÏÒµ¿ÉÒÔÂð

µ±È»¿ÉÒÔѽ
3Â¥2025-04-16 17:19:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÓÐÈË¿´µ½ÎҵĶú» µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[ÕÒ¹¤×÷] ɽ¶«¸ßУ½Ìʦ¿¼ºË³¬¼¶ÎÞµ×Ïߣ¬Ô±¹¤¹ý²»ÏÂÈ¥À² +3 qut2026 2026-04-09 7/350 2026-04-11 21:55 by doublecle
[¿¼ÑÐ] µ÷¼Á +6 ÔÂ@163.com 2026-04-11 6/300 2026-04-11 21:46 by lwk2004
[¿¼ÑÐ] 290Çóµ÷¼Á +11 luoziheng 2026-04-10 11/550 2026-04-11 21:45 by cfdbai
[¿¼ÑÐ] µ÷¼Á +5 ÎĵÀÐÇ̨ 2026-04-11 5/250 2026-04-11 15:01 by ¿­¿­Òª±ä˧
[¿¼ÑÐ] 327Çóµ÷¼Á +4 ʰ¹âÈÎȾ 2026-04-06 4/200 2026-04-11 12:01 by Delta2012
[¿¼ÑÐ] 316Çóµ÷¼Á +4 Ïë¶ÁÑо¿Éú( ?¡ß 2026-04-07 4/200 2026-04-11 11:43 by zhq0425
[¿¼ÑÐ] µ÷¼Á +12 ¾í¾í¾íÐIJË_ 2026-04-09 13/650 2026-04-10 22:36 by Ftglcn90
[¿¼ÑÐ] 284Çóµ÷¼Á +19 èó@@ 2026-04-06 21/1050 2026-04-10 21:12 by zhouxiaoyu
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Ê¦·¶ÉúÎïѧ326·Ö£¬Çóµ÷¼Á +8 Áõīī 2026-04-09 8/400 2026-04-10 12:00 by pengliang8036
[¿¼ÑÐ] Çóµ÷¼Á ²ÄÁÏÓ빤³Ì 324·Ö ר˶ +19 ôæôæÒ»ÊéÉú 2026-04-10 21/1050 2026-04-10 11:41 by wp06
[¿¼ÑÐ] Çóµ÷¼Á +11 ôæôæÒ»ÊéÉú 2026-04-09 13/650 2026-04-10 10:27 by liuhuiying09
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©273Çóµ÷¼Á +18 ÀóÌâÄÏǽ 2026-04-05 19/950 2026-04-10 08:14 by kangsm
[¿¼ÑÐ] 085601³õÊÔ330·ÖÕÒµ÷¼Á +10 Á÷ÐÄÄ̻ưül 2026-04-09 10/500 2026-04-10 08:14 by Sammy2
[¿¼ÑÐ] 348Çóµ÷¼Á +3 candyyyi 2026-04-09 3/150 2026-04-09 17:20 by ¶ÎΰÑÞ
[¿¼ÑÐ] µ÷¼Á +12 ÔÂ@163.com 2026-04-08 12/600 2026-04-09 14:27 by rl1980
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +13 ÏàÐűػá¹ââÍòÕ 2026-04-06 16/800 2026-04-09 13:54 by ÐìÁ¼°×ü´óÏÀ
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò©µ÷¼Á +7 awwwwwooooo 2026-04-09 7/350 2026-04-09 13:31 by ±±¼«159263
[¿¼ÑÐ] 293·ÖÇóµ÷¼Á£¬ÍâÓïΪ¶íÓï +7 ¼ÓÒ»Ò»¾Å 2026-04-07 10/500 2026-04-08 20:14 by yutian743
[¿¼ÑÐ] 277Çóµ÷¼Á ÊýÒ»104·Ö +9 Æ¿×ÓPZ 2026-04-05 14/700 2026-04-07 17:52 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ¿¼Ñе÷¼ÁÉúѰÕÒµ¼Ê¦ +3 ¹ËÕ°¿¼Ñа¡ 2026-04-05 3/150 2026-04-05 18:18 by à£à£à£0119
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û